# TRU-IMMUNO: Optimizing Liver Immunosuppression

> **NCT05335551** · — · UNKNOWN · sponsor: **Transplant Genomics, Inc.** · enrollment: 130 (estimated)

## Conditions studied

- Liver Transplant Rejection

## Interventions

- **DIAGNOSTIC_TEST:** Patients monitored with TruGraf and TRAC Liver testing

## Key facts

- **NCT ID:** NCT05335551
- **Lead sponsor:** Transplant Genomics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05
- **Primary completion:** 2023-05
- **Final completion:** 2023-05
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2022-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05335551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05335551, "TRU-IMMUNO: Optimizing Liver Immunosuppression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05335551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*